JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

The GUARDIAN study has been recognized as one of the most impactful scientific contributions published across all JAMA journals this year.
The Manila Times

The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extensio…

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...
Chicago Sun-Times

Alzheimer’s disease blood test could bring faster, more accurate diagnosis, researchers report Sunday, but which will work best?

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Nasdaq

Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat

RADNOR, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Nasdaq

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD ...

The DEPEND study demonstrates that checkpoint inhibitor nivolumab (Opdivo®) works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1 Multikine* is uniquely ...
NBC News

Race and health care collide in revealing American Medical Association controversy

This spring brought a shake-up within medicine's old guard: the American Medical Association, or AMA, and its associated journal, the Journal of the American Medical Association, or JAMA. Established ...